公开(公告)号：EP2064204A1

公开(公告)日：2009-06-03

申请号：EP07837478.2

申请日：2007-08-29

申请人： Merck & Co., Inc.

发明人： OGAWA, Anthony ,  UJJAINWALLA, Feroze ,  VANDE BUNTE, Ellen, K. ,  CHU, Lin ,  ONDEYKA, Debra ,  KOPKA, Ihor ,  LI, Bing ,  OK, Hyun ,  PATEL, Minal, J. ,  XU, Jinyou ,  SISCO, Rosemary

IPC分类号： C07D401/14 ,  C07D413/14 ,  C07D417/14 ,  A61K31/4427 ,  A61K31/501 ,  A61P9/10

CPC分类号： C07D413/14 ,  C07D401/14 ,  C07D417/14

摘要： The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.